Treatment of pml targeting jc virus agno
CA 2467930 C · Owner: Okada, Yuki · Inventors: Okada, Yuki; Nagashima, Kazuo; Sawa, Hirofumi
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
It is intended to provide an effective method of treating PML (human progressive multifocal leukoencephalopathy). A method of inhibiting the proliferation of JC virus in JC virus-infected cells by inhibiting the expression of JV virus agno gene; and a method of inhibiting the canceration of JC virus-infected cells.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 5, 2002 and granted February 19, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended June 5, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 5, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.